Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16988.9US
CV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBKORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBKENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBKNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.14.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.14.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.14.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DF.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
DF.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used